Prostate Cancer - Results from #60

Hot Flashes: Clinical Summary of the ONS Guidelines™ for Cancer Treatment-Related Hot Flashes in Women With Breast Cancer and Men With Prostate Cancer. July 23, 2020

Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer. July 23, 2020

Current techniques of prostate biopsy: an update from past to present. July 23, 2020

Prostate cancer biology & genomics. July 23, 2020

Successful management of prostate cancer with bulky pelvic lymph node metastases after rapid development of castration-resistant prostate cancer: a case report with review of the literature. July 23, 2020

Metastatic Prostate Cancer: An Update on Treatments and a Review of Patient Symptom Management. July 23, 2020

A systematic review of salvage focal therapies for localised non-metastatic radiorecurrent prostate cancer. July 23, 2020

Social and medical risk factors associated with supportive needs in the first year following localized prostate cancer treatment. July 23, 2020

Prospective assessment of two-gene urinary test with multiparametric magnetic resonance imaging of the prostate for men undergoing primary prostate biopsy. July 23, 2020

Prognostic value of testosterone for the castration-resistant prostate cancer patients: a systematic review and meta-analysis. July 23, 2020

PI-RADS score v.2 in predicting malignancy in patients undergoing 5α-reductase inhibitor therapy. July 23, 2020

Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patients. July 23, 2020

Acetylation-mediated degradation of HSD17B4 regulates the progression of prostate cancer. July 22, 2020

Comparison of machine learning algorithms to predict clinically significant prostate cancer of the peripheral zone with multiparametric MRI using clinical assessment categories and radiomic features. July 22, 2020

PAX3 silencing inhibits prostate cancer progression through the suppression of the TGF-β/Smad signaling axis. July 22, 2020

Fundamentals of liquid biopsies in metastatic prostate cancer: from characterization to stratification. July 22, 2020

Targeting defective DNA repair in prostate cancer. July 22, 2020

Blue Earth Diagnostics Announces Dosing of Initial Patients in Phase 3 SPOTLIGHT Clinical Trial of Targeted PET Imaging Agent rhPSMA-7.3 (18F) in Biochemically Recurrent Prostate Cancer July 21, 2020

The Prostate Cancer Foundation and Robert F. Smith Announce New Effort to Address Health Disparities for African American Men July 21, 2020

Contrast-enhanced transrectal ultrasound can reduce collection of unnecessary biopsies when diagnosing prostate cancer and is predictive of biochemical recurrence following a radical prostatectomy in patients with localized prostate cancer. July 21, 2020

Page 4 of 1093